Risk Factors for Prosthesis Failure in Pulmonary Valve Replacement

Slides:

Advertisements

Similar presentations

Twenty-Five Year Experience With the St

Advertisements

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Reply The Annals of Thoracic Surgery

Outcomes of Reintervention on the Autograft After Ross Procedure

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N

Pulmonary Valve Replacement: A Comparison of Three Biological Valves

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Pulmonary Valve Replacement With Balloon-Expandable Prosthesis Under Direct Vision: A Novel Therapeutic Approach Yi Lin, MD, Joseph A. Dearani, MD, Donald.

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Harm H. H. Feringa, MD, Leslee J

Hypoplastic Left Heart Syndrome, Interrupted Inferior Vena Cava, Biliary Atresia Michiaki Imamura, MD, PhD, Umesh Dyamenahalli, MD, Ritu Sachdeva, MD,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Right Gastroepiploic Artery Graft for Myocardial Revascularization: Prevalence of Atherosclerosis and Availability as a Conduit Kwang Ree Cho, MD, PhD,

Chronic Atrial Fibrillation Is Associated With Reduced Survival After Aortic and Double Valve Replacement Richard Schulenberg, MD, Polychronis Antonitsis,

Outcomes of Early Mitral Valve Reoperation in the Medicare Population

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Long-Term Outcomes of the Mosaic Bioprosthesis

Pleural Metastasis of Osteosarcoma

Durability of Homografts Used to Treat Complex Aortic Valve Endocarditis Willem Flameng, MD, PhD, Willem Daenen, MD, Ramadan Jashari, MD, Paul Herijgers,

Origins of the Cardiothoracic Surgery Network (CTSNet)

Who Do You Say You Are? The Annals of Thoracic Surgery

Which Patients Benefit From Stentless Aortic Valve Replacement?

Outcomes of Mechanical Valves in the Pulmonic Position in Patients With Congenital Heart Disease Over a 20-Year Period Hong Ju Shin, MD, Young-Hwue Kim,

Use of Amiodarone After Major Lung Resection

Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D

Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Percutaneous Transcatheter Closure of the Aortic Valve

Redo Aortic Valve Replacement in Children

Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival Marc R. Moon, MD, Michael K. Pasque, MD, Nabil.

Robert W. Emery, MD, Christopher C. Krogh, Kit V. Arom, MD, PhD, Ann M

Editorial Board, January 2010

Mohammad A. Zafar, MBBS, Emily A

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Midterm Outcome of Valve-Sparing Aortic Root Replacement in Inherited Connective Tissue Disorders Hiroshi Tanaka, MD, PhD, Hitoshi Ogino, MD, PhD, Hitoshi.

Pulmonary Homograft Monocusp Reconstruction of the Right Ventricular Outflow Tract: Outcomes to the Intermediate Term Dilip S. Nath, MD, Daniel P. Nussbaum,

Bhawna Gupta, PhD, Ali Dodge-Khatami, MD, PhD, Charles D

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

Pulmonary Valve Replacement for Pacing Electrodes Related Bacterial Endocarditis Vilém Rohn, MD, PhD, Marek Šlais, MD, Tomáš Kotulák, MD, Michal Pšenička,

Effect of Prosthesis-Patient Mismatch on Long-Term Survival With Aortic Valve Replacement: Assessment to 15 Years W.R. Eric Jamieson, MD, Jian Ye, MD,

Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD

An Increased Incidence of Conduit Endocarditis in Patients Receiving Bovine Jugular Vein Grafts Compared to Cryopreserved Homograft for Right Ventricular.

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis Ariel Beresniak, MD, PhD, Brigitte Sabatier, PharmD,

Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe.

Invited Commentary The Annals of Thoracic Surgery

Ventricular Pacing Through Coronary Sinus in Patients With Tricuspid Prosthesis Caroline Grimard, MD, Nicolas Clémenty, MD, Laurent Fauchier, MD, PhD,

Robert Lee Replogle, September 30, 1931–May 9, 2016

Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J

Christoph P. Hornik, MD, Xia He, MS, Jeffrey P. Jacobs, MD, Jennifer S

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Comparing Aortic Root Replacements: Porcine Bioroots Versus Pericardial Versus Mechanical Composite Roots: Hemodynamic and Ventricular Remodeling at Greater.

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Paul A. Pirundini, MD, Jorge M. Balaguer, MD, Kevin J

Late Consequences of a Much Earlier Decision

Justin P. V. Zachariah, MD, Frank A. Pigula, MD, John E

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? Asvin M. Ganapathi,

Risk of Valve-Related Events After Aortic Valve Repair

Early and Late Outcomes of Aortic Valve Replacement in Dialysis Patients Keisuke Tanaka, MD, Kazuyoshi Tajima, MD, Yoshiyuki Takami, MD, Noritaka Okada,

Presentation transcript:

Risk Factors for Prosthesis Failure in Pulmonary Valve Replacement Rahel Zubairi, MD, Sadia Malik, MD, Robert D.B. Jaquiss, MD, Michiaki Imamura, MD, PhD, Jeff Gossett, MS, W. Robert Morrow, MD The Annals of Thoracic Surgery Volume 91, Issue 2, Pages 561-565 (February 2011) DOI: 10.1016/j.athoracsur.2010.07.111 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Number of valve types shown by year of implantation. (BP = bovine pericardial valve; PH = pulmonary homograft; XV = xenograft porcine valve; XVC = xenograft porcine valve in a Dacron conduit.) The Annals of Thoracic Surgery 2011 91, 561-565DOI: (10.1016/j.athoracsur.2010.07.111) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall freedom from prosthetic valve failure is shown for all valve types. The Annals of Thoracic Surgery 2011 91, 561-565DOI: (10.1016/j.athoracsur.2010.07.111) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Freedom from prosthetic valve failure is shown by valve type. ((BP = pericardial bioprosthesis; PH = pulmonary homograft; XV = porcine valve; XVC = porcine valve in a Dacron conduit.) The Annals of Thoracic Surgery 2011 91, 561-565DOI: (10.1016/j.athoracsur.2010.07.111) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Freedom from prosthetic valve failure is shown for homografts (red line) vs heterograft (blue line) of all types. The Annals of Thoracic Surgery 2011 91, 561-565DOI: (10.1016/j.athoracsur.2010.07.111) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Freedom from prosthetic valve failure by age < 5 years (red line), 5 to 10 years (blue line), and > 10 years (green line). The Annals of Thoracic Surgery 2011 91, 561-565DOI: (10.1016/j.athoracsur.2010.07.111) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 6 Early (solid line) and late-phase (dashed line) prosthetic valve failure is shown. The Annals of Thoracic Surgery 2011 91, 561-565DOI: (10.1016/j.athoracsur.2010.07.111) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions